AbbVie Close to $8 Billion Deal for Cerevel Therapeutics, Sources Say, Reuters Reports
December 06 2023 - 4:59PM
Dow Jones News
--AbbVie is close to a deal to acquire Cerevel Therapeutics
Holdings for about $8 billion, Reuters reports, citing people
familiar with the matter.
--AbbVie is in talks to pay around $45 a share for Cerevel,
which develops drugs for neurological conditions.
--AbbVie and Cerevel didn't immediately respond to requests for
comment from Reuters.
Full article at
https://www.reuters.com/markets/deals/abbvie-nears-roughly-8-billion-drug-developer-cerevel-sources-2023-12-06/
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
December 06, 2023 16:44 ET (21:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From May 2024 to Jun 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2023 to Jun 2024